About the Authors
- David B. Shultz
-
Affiliation Princess Margaret Cancer Centre, Toronto, Ontario, Canada
- Jonathan Pai
-
Affiliation School of Medicine, University of California San Francisco, San Francisco, United States of America
- Wayland Chiu
-
Affiliation Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America
- Kendall Ng
-
Affiliation Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America
- Madeline G. Hellendag
-
Affiliation Kaiser Permanente Medical Center, San Francisco, United States of America
- Gregory Heestand
-
Affiliation Moores Cancer Center, University of California San Diego, La Jolla, CA, United States of America
- Daniel T. Chang
-
Affiliation Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America
- Dongsheng Tu
-
Affiliation NCIC Clinical Trials Group, Queen's University, Kingston, Canada
- Malcolm J. Moore
-
Affiliation British Columbia Cancer Agency, Vancouver, British Columbia, CA, United States of America
- Wendy R. Parulekar
-
Affiliation NCIC Clinical Trials Group, Queen's University, Kingston, Canada
- Albert C. Koong
-
* E-mail: akoong@stanford.edu
Affiliation Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America
Competing Interests
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: GH has served as a consultant for Bayer, Merrimack, and Genomic Health. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DS WP AK. Performed the experiments: JP WC KN MH GH DT. Analyzed the data: DS JP WC KN MH DT WP AK. Contributed reagents/materials/analysis tools: MH GH MM WP AK. Wrote the paper: DS DC AK.